APA (7th ed.) Citation

Lee, S. H., Yim, S. Y., Kim, J. H., Lee, S. S., Kaseb, A. O., & Lee, J. Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 Trial”. Korean Association for the Study of the Liver.

Chicago Style (17th ed.) Citation

Lee, Sung Hwan, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, and Ju-Seog Lee. Correspondence to Editorial 1 on “Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial”. Korean Association for the Study of the Liver.

MLA (9th ed.) Citation

Lee, Sung Hwan, et al. Correspondence to Editorial 1 on “Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial”. Korean Association for the Study of the Liver.